BIOSANTE PHARM (BPAX) – StreetInsider.com Reports
-
Unusual 11 Mid-Day Movers 06/21: (ORMP) (SPRD) (MBIS) Higher; (IDIX) (BPAX) (EBIX) Lower
-
BioSante (BPAX), ANIP Acquisition Announce Date of Special Meeting in Proposed Merger
-
Notable Mergers and Acquisitions of the Day 10/04: (BPAX) (MMM)/(AVY) (ZAZA) (CBAI)
-
BioSante Pharma (BPAX) to resume trading at 9:45am ET
-
BioSante Pharmaceuticals (BPAX) in Merger Deal with ANI Pharmaceuticals
-
BioSante Pharmaceuticals, Inc. (BPAX) halted, news pending
-
BioSante Pharma (BPAX) Closes 2.36M Direct Offering; Nets $3.3M
-
BioSante (BPAX) Enters $3.48M Registered Direct Offering
-
Unusual 11 Mid-Day Movers 06/18: (XG) (IDCC) (JRJC) Higher; (BODY) (KV-A) (DSW) Lower
-
Morning Movers 06/15: (BVSN) (YPF) (BPAX) Higher; (IIVI) (DYAX) (IVN) Lower
-
BioSante (BPAX) to Start Two New LibiGel Phase IIIs for Efficacy Evaluation
-
BioSante (BPAX) Volatility Elevated into LibiGel Presentation at Jefferies Conference; Shares Higher
-
Unusual 11 Mid-Day Movers 06/05: (AMRS) (WPRT) (BPAX) Higher; (EDS) (SHFL) (CBLI) Lower
-
Morning Movers 06/05: (BPAX) (AMRS) (PSUN) Higher; (EDS) (SHFL) (CBLI) (TAST) Lower
-
Biosante Pharma (BPAX) Volatility Elevated on Trader Profit Taking
-
Biosante Pharma (BPAX) Volatility Up as Shares Run Nearly 50%
-
BioSante (BPAX) Reports Encouraging Data from Recent Pill-Plus Studies
-
BioSante Pharmaceuticals (BPAX) Report FY11 Financials
-
BioSante Pharma (BPAX) Reports Encouraging Data from GVAX in mCRPC Phase I w/ Escalated Dosage
-
Unusual 11 Midday Movers 02/27: (ALIM) (BPAX) (ATPG) (CAAS) Higher; (DNDN) (IMI) (BCPC) Lower
-
Morning Movers 02/27: (BPAX) (ATPG) (PEIX) (ALIM) Higher; (DNDN) (IMI) (BCPC) Lower
-
Pre-Open Movers 2/27 (TBET) (LNG) (PCS) Higher; (CBRX) (DNDN) (NFLX) Lower (more...)
-
BioSante (BPAX) Rips Higher Following Strong GVAX Phase Ib Data
-
BioSante Pharmaceuticals (BPAX) Announces Results for Phase Ib Clinical Study GVAX Pancreas Cancer Vaccine
-
BioSante (BPAX) GVAX Pancreas Cancer Vaccine Said to Increase Median Survival Rate
-
Morning Movers 02/16: (AEA) (ITRI) (BDSI) (TRW) Higher; (HDY) (BBW) (ACOM) (PMFG) Lower
-
Unusual 11 Midday Movers 02/15: (BPAX) (EGY) (THLD) Higher; (ZNGA) (PWAV) (IPSU) Lower
-
BioSante (BPAX) Gets FDA Approval for Bio T-Gel
-
Morning Movers 02/15: (BPAX) (EGY) (IPAS) (CBK) Higher; (VG) (ZNGA) (ACPW) Lower
-
Pre-Open Movers 2/15: (BPAX) (CMCSA) (HIG) Higher; (ACPW) (ZNGA) (PEET) Lower (more...)
-
BioSante (BPAX) Surges on FDA Clearance for Bio-T Gel
-
After-Hours Movers 02/14: (BPAX) (GIVN) (HIG) (INWK) Higher; (PWAV) (ACPW) (ZNGA) Lower
-
BioSante (BPAX), Teva (TEVA) Receive FDA Approval for Bio-T-Gel -Bloomberg
-
BioSante (BPAX) Reports Positive Review from Independent DMC for LibiGel Phase III
-
BioSante (BPAX) Enters Agreement to Cancel $5M of Debt, Will Issue 6.7M Common in Deal
-
Unusual 11 Midday Movers 02/07: (SATC) (MNI) (CSTR) (SPF) Higher; (NSU) (CBM) (ASTX) Lower
-
Morning Movers 02/07: (SATC) (BMTI) (CSTR) (MNI) Higher; (ASTX) (ACHN) (BVSN) Lower
-
Pre-Open Movers 2/7: (CSTR) (FN) (NCR) Higher; (KNXA) (CFX) (RATE) Lower (more...)
-
BioSante Pharmaceuticals (BPAX) Continues Higher After Bullish Article
-
BioSante (BPAX) Evaluating Corporate Strategy Following LibiGel Phase III Results
-
Unusual 11 Midday Movers 12/28: (PRXI) (SQNS) (ACAT) Higher; (MCP) (PERF) (ZAGG) Lower
-
Stocks with implied volatility below IV index mean; VRUS BPAX
-
Stocks with implied volatility below IV index mean; VRUS BPAX
-
Notable 52-Week Highs and Lows of the Day 12/19: (HEK) (SPPI) (V) High; (BAC) (EGO) (BPAX) Low
-
Put option volume increases: BPAX ARMH DECK
-
Stocks with implied volatility below IV index mean; AMR BPAX
-
Notable 52-Week Highs and Lows of the Day 12/15: (PFE) (LLY) High; (RIMM) (BPAX) (ITMN) Low
-
Unusual 11 Mid-Day Movers 12/15: (SPMD) (OKSB) (ZOLL) Higher; (BPAX) (AIS) (ATHN) Lower
-
Morning Movers 12/15: (SPMD) (SONO) (NVLS) (CEDC) Higher; (BPAX) (AIS) (ITMN) Lower
-
Pre-Open Movers 12/154: (SONO) (NVLS) (FDX) Higher; (BPAX) (IPSU) (DECK) Lower (more...)
Back to BPAX Stock Lookup